We then used low-dose ouabain to treat fibroblasts and tumor cells and found that NF-κB signaling and activin A production were specifically induced in fibroblasts, but not in tumor cells (Supplementary Fig. 7b, c). Here, NFKB1 is linked to neoplasm.